Search Form
First, enter a politician or zip code
Now, choose a category
 

Bart Stupak's Public Statements on Issue: Drugs

Date Title
Issue Position: Medicare
Oct. 28, 2010 Seniors in Northern Michigan Receive "Donut Hole" Checks to Combat High Drug Costs
Sept. 29, 2010 Secure And Responsible Drug Disposal Act Of 2010
Sept. 22, 2010 Safe Drug Disposal Act Of 2010
Sept. 20, 2010 Waxman, Dingell, Pallone & Stupak Open Discussion on Potentially Historic Changes in Drug Safety Laws
July 22, 2010 Hearing of the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce - "Direct-To-Consumer Genetic Testing and the Consequences to the Public Health"
July 13, 2010 Bi-Partisan Group of Lawmakers Team Up to Combat Prescription Drug Abuse
June 10, 2010 Filling the Doughnut Hole
March 4, 2010 Seniors Receive Assistance With Prescription Drug Costs
Dec. 7, 2009 Stupak Reminds Seniors Of Medicare Prescription Drug Program Open Enrollment
Oct. 1, 2009 Stupak Urges Prescription Drugs Negotiation Be Retained In Health Reform
March 26, 2009 Hearing of the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce - Institutional Review Boards that Oversee Experimental Human Testing for Profit
Feb. 11, 2009 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - "The Salmonella Outbreak: The Continued Failure to Protect the Food Supply"
Jan. 14, 2009 Stupak Introduces Bill to Expand Drug Discounts for Rural Health Providers
June 24, 2008 House Members Introduce Bipartisan Bill to Improve Safety of Online Pharmacies
April 30, 2008 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Heparin Disaster: Chinese Counterfeits and American Failures
April 29, 2008 Hearing of the House Energy and Commerce Committee - The Heparin Disaster: Chinese Counterfeits and American Failures
April 22, 2008 Panel I of a Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Food and Drug Administration's Foreign Drug Inspection Program
April 22, 2008 Panel II of a Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Food and Drug Administration's Foreign Drug Inspection Program: Weaknesses Place America at Risk
March 5, 2008 Stupak Leads Bipartisan Coalition in Urging Restoration of Byrne-JAG Funding
Feb. 12, 2008 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Ketek Clinical Study Fraud: What Did Aventis Know?
Jan. 25, 2008 Dingell, Stupak Comment on FDA Plan for Overseas Inspections
Jan. 23, 2008 Dingell, Stupak Comment on Decision to Pull Vytorin Ads
Jan. 16, 2008 CBS "The Early Show" - Transcript
Jan. 7, 2008 Committee Opens Investigation into Celebrity Drug Endorsements
Nov. 1, 2007 Hearing of the Subcommittee on Oversight & Investigations of the House Committee on Energy and Commerce - FDA Foreign Drug Inspection Program
Oct. 11, 2007 Hearing of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee, Panel I - Security of the Nation's Food Supply?
Oct. 11, 2007 Hearing of the House Energy and Commerce Committee's Oversight and Investigations Subcommittee, Panel III- Security of the Nation's Food Supply?
July 23, 2007 Stupak Introduces Bill to Expand Drug Rebate Program
June 11, 2007 Hinchey & Stupak: FDA's Bond With Drug Industry Is As Strong As Ever
June 11, 2007 Letter to The Honorable Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration, Department of Health and Human Services
March 14, 2007 Whistleblower Protection Enhancement Act of 2007
Feb. 7, 2007 U.S. House Passes Bill to Clean Up Meth Labs
Feb. 6, 2007 Letter: To Andrew C. von Eschenbach, M.D., Commissioner, Food and Drug Administration
Sept. 5, 2006 Letter to Comptroller General of the United States David M. Walker
April 5, 2006 Bush Prescription Drug Tax Countdown
March 9, 2006 Providing for Consideration of H.R. 2829, Office of National Drug Control Policy Reauthorization Act of 2005
July 27, 2005 National All Schedules Prescription Electronic Reporting Act of 2005
June 14, 2005 Effects of Accutane
June 14, 2005 Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2006
June 13, 2005 Byrne-Justice Assistance Grant Amendment
May 11, 2005 Paying Tribute to National Law Enforcement Officers and First Responders
May 4, 2005 Drug Safety
Nov. 19, 2004 Statement of Rep. Bart Stupak (D-MI) 11/18 Senate Committee Hearing on FDA Oversight/Regulation of Prescription Drugs
Nov. 19, 2004 Accutane
Sept. 30, 2004 Accutane's Impact on Brian
Sept. 29, 2004 The Need for More Research and Management of Risk of Accutane
Jan. 21, 2004 Responding to State of The Union Message
Skip to top
Back to top